| William Natale, MD | |
|
6th Ave And Spruce St, W. Reading, PA 19611 | |
| (610) 988-8615 | |
| Not Available |
| Full Name | William Natale |
|---|---|
| Gender | Male |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 6th Ave And Spruce St, W. Reading, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538167135 | NPI | - | NPPES |
| 001491665 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | MD053432L (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| William Natale, MD 50 Commerce Dr, Wyomissing, PA 19610-3335 Ph: (610) 372-8044 | William Natale, MD 6th Ave And Spruce St, W. Reading, PA 19611 Ph: (610) 988-8615 |
News Archive
Two new studies by researchers at Hospital for Special Surgery have shed light on joint replacement outcomes in patients with rheumatoid arthritis. One study overturns the common belief that RA patients have worse outcomes after a total knee replacement than patients who undergo the operation for osteoarthritis. The other study demonstrates that RA patients who undergo a total hip replacement were as likely to have significant improvements in function and pain as patients with osteoarthritis, even though they did not do as well.
For a small percentage of cancer patients, treatment aimed at curing the disease leads to a form of leukemia with a poor prognosis. Conventional thinking goes that chemotherapy and radiation therapy induce a barrage of damaging genetic mutations that kill cancer cells yet inadvertently spur the development of acute myeloid leukemia (AML), a blood cancer.
Taking the bus is a whole lot safer than taking the car – and it's also safer for cyclists and pedestrians who take the same routes, according to a new study led by the Université de Montréal Public Health Research Institute (IRSPUM).
Genomic mutation testing is critical to therapeutic selection and management of patients with colorectal cancer. In a new multicenter study, researchers compared a new cartridge-based laboratory testing device called the Idylla automated system (Biocartis) to current standard-of-care testing methods.
› Verified 9 days ago
William Kimmel, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 6th Ave And Spruce St, W. Reading, PA 19611 Phone: 610-988-8615 |